Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Nozomu Yoshino"'
Autor:
Yosuke Okada, Hideki Nakasone, Shunto Kawamura, Kosuke Takano, Kazuki Yoshimura, Masaharu Tamaki, Akari Matsuoka, Takuto Ishikawa, Tomohiro Meno, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Machiko Kusuda, Aki Tanihara, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The recent progress with ruxolitinib treatment might improve quality-of-life as well as overall survival in patients with primary myelofibrosis (PMF). Therefore, the optimal timing of allogeneic hematopoietic cell transplantation (HCT) remains to be
Externí odkaz:
https://doaj.org/article/28b2079e445a4803ae75cf11cf0780fb
Autor:
Hideki Nakasone, Machiko Kusuda, Kiriko Terasako-Saito, Koji Kawamura, Yu Akahoshi, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Kazuki Yoshimura, Yukiko Misaki, Ayumi Gomyo, Kazuaki Kameda, Masaharu Tamaki, Aki Tanihara, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-18 (2021)
Cytomegalovirus reactivation is an important concern after allogeneic stem cell transplantation (allo-HCT) or organ transplantation. Here, Hideki Nakasone et al. investigate changes in repertoire diversity and gene expression among clinically-transfe
Externí odkaz:
https://doaj.org/article/820c858c9fc746ddad6e2e857de049ca
Autor:
Yu Akahoshi, Hideki Nakasone, Koji Kawamura, Machiko Kusuda, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Aki Tanihara, Masaharu Tamaki, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3287-3296 (2019)
Abstract: Macrophages play a crucial role in the pathogenesis of chronic graft-versus-host disease (cGVHD). We hypothesized that galectin-3, Mac-2 binding protein (M2BP), or Wisteria floribunda agglutinin (WFA)+-M2BP, called M2BP glycan isomer (M2BPG
Externí odkaz:
https://doaj.org/article/c0fe1855a6154d2fa0d563f84e0092bb
Autor:
Nozomu Yoshino, Shun-ichi Kimura, Akari Matsuoka, Tomohiro Meno, Takuto Ishikawa, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Yosuke Okada, Masaharu Tamaki, Yu Akahoshi, Machiko Kusuda, Kazuaki Kameda, Aki Tanihara, Hidenori Wada, Hideki Nakasone, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
Journal of Infection and Chemotherapy. 29:384-390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de4154b5b8b80b2282ebdeb49e0d3560
https://doi.org/10.1016/j.jiac.2023.01.004
https://doi.org/10.1016/j.jiac.2023.01.004
Autor:
Yukiko Misaki, Daisuke Minakata, Tatsuro Ibe, Ayumi Gomyo, Kazuki Yoshimura, Shun-ichi Kimura, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Shimpei Matsumi, Yu Akahoshi, Masaharu Tamaki, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Koji Kawamura, Miki Sato, Kiriko Terasako-Saito, Aki Tanihara, Kaoru Hatano, Hideki Nakasone, Ken-ichi Imadome, Hiroshi Wada, Shinichi Kako, Hisashi Oshiro, Akira Tanaka, Yoshinobu Kanda
Publikováno v:
Journal of Infection and Chemotherapy. 29:212-218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d677bdde25d1b88af5f30c388193653
https://doi.org/10.1016/j.jiac.2022.10.013
https://doi.org/10.1016/j.jiac.2022.10.013
Autor:
Machiko Kusuda, Hideki Nakasone, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Aki Tanihara, Masaharu Tamaki, Kazuaki Kameda, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
International Journal of Hematology. 117:198-205
Acute myeloid leukemia (AML) is a malignancy that requires immediate treatment. However, the factors that predict very early mortality are not well known. We retrospectively analyzed 70 patients who were newly diagnosed with AML at our institution be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ad9ec4a2c9adff5603c915653081857
https://doi.org/10.1007/s12185-022-03482-x
https://doi.org/10.1007/s12185-022-03482-x
Autor:
Masaharu Tamaki, Hideki Nakasone, Yuhei Nakamura, Masakatsu Kawamura, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Aki Tanihara, Yosuke Okada, Machiko Kusuda, Kazuaki Kameda, Yu Akahoshi, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
Leukemia & Lymphoma. 63:2197-2205
Idiopathic pneumonia syndrome (IPS) is a fatal pulmonary complication after allogeneic hematopoietic stem cell transplantation (allo-HCT). However, it is often difficult to diagnose IPS, since a considerable number of IPS patients are critically ill,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc4f18df7260e1e87a1fd39e1706cbd
https://doi.org/10.1080/10428194.2022.2057486
https://doi.org/10.1080/10428194.2022.2057486
Autor:
Yu Akahoshi, Hideki Nakasone, Machiko Kusuda, Kazuaki Kameda, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Aki Tanihara, Masaharu Tamaki, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
International Journal of Hematology. 115:748-752
Disease relapse is a major cause of treatment failure after allogeneic hematopoietic cell transplantation (HCT) and the mechanisms of relapse remain unclear. We encountered a 58-year-old man with chronic myelomonocytic leukemia (CMML) that relapsed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b581019ad5efaf8a2c4c5e23991404ca
https://doi.org/10.1007/s12185-021-03284-7
https://doi.org/10.1007/s12185-021-03284-7
Autor:
Shunto Kawamura, Masaharu Tamaki, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Yosuke Okada, Yu Akahoshi, Machiko Kusuda, Kazuaki Kameda, Aki Tanihara, Shun-ichi Kimura, Hideki Nakasone, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
Acta Haematologica. 145:553-559
TEMPI syndrome is a rare disease associated with plasma cell neoplasms. Although previous studies have reported that bortezomib is effective as a first-line treatment for TEMPI syndrome, some cases are refractory to this treatment. Pomalidomide, a ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbca4b0bc2b4fcc3f953c5c3c4e2fee0
https://doi.org/10.1159/000525056
https://doi.org/10.1159/000525056
Autor:
Shun-Ichi Kimura, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Yosuke Okada, Yu Akahoshi, Masaharu Tamaki, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Miki Sato, Aki Tanihara, Hideki Nakasone, Shinichi Kako, Yoshinobu Kanda
Publikováno v:
Acta Haematologica. 145:404-411
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a1f6c15f33781725e66ddb8a712dc6
https://doi.org/10.1159/000522037
https://doi.org/10.1159/000522037